Protist ◽  
1999 ◽  
Vol 150 (2) ◽  
pp. 137-147 ◽  
Author(s):  
Anne Baroin Tourancheau ◽  
Loic Morin ◽  
Tie Yang ◽  
Roland Perasso

2015 ◽  
Vol 6 ◽  
Author(s):  
Assaf Sukenik ◽  
Iris Maldener ◽  
Thomas Delhaye ◽  
Yehudit Viner-Mozzini ◽  
Dotan Sela ◽  
...  

2021 ◽  
Vol 55 (1) ◽  
pp. 63-69
Author(s):  
V.I. Oshurkova ◽  
◽  
Е.А. Deshevaya ◽  
N.E. Suzina ◽  
N.E. Shubralova ◽  
...  

Next phase of experiment TEST is aimed to evaluate microbial viability after a prolonged external exposure on the International space station (ISS). Methanogenic archaea isolated from various habitats have been tested in ground facilities for the ability to survive exposure to such open space factors as UV and vacuum. Methanosarcina mazei S-6T (VKM B-1636T) was found to be the most viable and, therefore, suitable for the experiment. Our investigations showed that the Methanosarcina mazei population maintained viability in the course of 24-month exposure. On this evidence we conclude that genome of this metanogenic archaea possesses mechanisms against the space vacuum, UV and thermal differences that, probably, underlie the ability of the strain to form peculiar cyst-like dormant cells.


2018 ◽  
Vol 2 (3) ◽  
pp. 177-188 ◽  
Author(s):  
Jean-François Spinella ◽  
Chantal Richer ◽  
Pauline Cassart ◽  
Manon Ouimet ◽  
Jasmine Healy ◽  
...  

Key Points Two distinct evolutionary patterns govern early and late relapse. Evolutionary patterns suggest a mutation-driven resistance for early relapses and a re-expansion of dormant cells for late ones.


2019 ◽  
Vol 85 (7) ◽  
Author(s):  
Alexander Burkert ◽  
Thomas A. Douglas ◽  
Mark P. Waldrop ◽  
Rachel Mackelprang

ABSTRACTPermafrost hosts a community of microorganisms that survive and reproduce for millennia despite extreme environmental conditions, such as water stress, subzero temperatures, high salinity, and low nutrient availability. Many studies focused on permafrost microbial community composition use DNA-based methods, such as metagenomics and 16S rRNA gene sequencing. However, these methods do not distinguish among active, dead, and dormant cells. This is of particular concern in ancient permafrost, where constant subzero temperatures preserve DNA from dead organisms and dormancy may be a common survival strategy. To circumvent this, we applied (i) LIVE/DEAD differential staining coupled with microscopy, (ii) endospore enrichment, and (iii) selective depletion of DNA from dead cells to permafrost microbial communities across a Pleistocene permafrost chronosequence (19,000, 27,000, and 33,000 years old). Cell counts and analysis of 16S rRNA gene amplicons from live, dead, and dormant cells revealed how communities differ between these pools, how they are influenced by soil physicochemical properties, and whether they change over geologic time. We found evidence that cells capable of forming endospores are not necessarily dormant and that members of the classBacilliwere more likely to form endospores in response to long-term stressors associated with permafrost environmental conditions than members of theClostridia, which were more likely to persist as vegetative cells in our older samples. We also found that removing exogenous “relic” DNA preserved within permafrost did not significantly alter microbial community composition. These results link the live, dead, and dormant microbial communities to physicochemical characteristics and provide insights into the survival of microbial communities in ancient permafrost.IMPORTANCEPermafrost soils store more than half of Earth’s soil carbon despite covering ∼15% of the land area (C. Tarnocai et al., Global Biogeochem Cycles 23:GB2023, 2009, https://doi.org/10.1029/2008GB003327). This permafrost carbon is rapidly degraded following a thaw (E. A. G. Schuur et al., Nature 520:171–179, 2015, https://doi.org/10.1038/nature14338). Understanding microbial communities in permafrost will contribute to the knowledge base necessary to understand the rates and forms of permafrost C and N cycling postthaw. Permafrost is also an analog for frozen extraterrestrial environments, and evidence of viable organisms in ancient permafrost is of interest to those searching for potential life on distant worlds. If we can identify strategies microbial communities utilize to survive in permafrost, it may yield insights into how life (if it exists) survives in frozen environments outside of Earth. Our work is significant because it contributes to an understanding of how microbial life adapts and survives in the extreme environmental conditions in permafrost terrains.


2019 ◽  
Vol 63 (7) ◽  
Author(s):  
Angelo Iacobino ◽  
Federico Giannoni ◽  
Manuela Pardini ◽  
Giovanni Piccaro ◽  
Lanfranco Fattorini

ABSTRACTThe activities of rifampin, nitazoxanide, PA-824, and sutezolid were tested against dormantMycobacterium tuberculosisunder conditions mimicking caseous granulomas (hypoxia at pH 7.3) in comparison with those of the combination rifampin-isoniazid-pyrazinamide-ethambutol (R-I-Z-E), which is used for human therapy. Mycobacterial viability was monitored by CFU and regrowth in MGIT 960. As shown by lack of regrowth in MGIT, rifampin-nitazoxanide-containing combinations, but not R-I-Z-E, killed dormant cells in 28 to 35 days. These observations might be important in designing new tuberculosis therapies.


Biofilm ◽  
2020 ◽  
Vol 2 ◽  
pp. 100018 ◽  
Author(s):  
Thomas K. Wood ◽  
Sooyeon Song
Keyword(s):  

2010 ◽  
Vol 54 (10) ◽  
pp. 4150-4158 ◽  
Author(s):  
Claudia Sala ◽  
Neeraj Dhar ◽  
Ruben C. Hartkoorn ◽  
Ming Zhang ◽  
Young Hwan Ha ◽  
...  

ABSTRACT Nonreplicating or dormant cells of Mycobacterium tuberculosis constitute a challenge to tuberculosis (TB) therapy because of their tolerance or phenotypic resistance to most drugs. Here, we propose a simple model for testing drugs against nongrowing cells that exploits the 18b strain of M. tuberculosis, a streptomycin (STR)-dependent mutant. Optimal conditions were established that allowed 18b cells to replicate in the presence of STR and to survive, but not multiply, following withdrawal of STR. In the presence of the antibiotic, M. tuberculosis 18b was susceptible to the currently approved TB drugs, isoniazid (INH) and rifampin (RIF), and to the experimental drugs TMC207, PA-824, meropenem (MER), benzothiazinone (BTZ), and moxifloxacin (MOXI). After STR depletion, the strain displayed greatly reduced susceptibility to the cell wall inhibitors INH and BTZ but showed increased susceptibility to RIF and PA-824, while MOXI and MER appeared equipotent under both conditions. The same potency ranking was found against nonreplicating M. tuberculosis 18b after in vivo treatment of chronically infected mice with five of these drugs. Despite the growth arrest, strain 18b retains significant metabolic activity in vitro, remaining positive in the resazurin reduction assay. Upon adaption to a 96-well format, this assay was shown to be suitable for high-throughput screening with strain 18b to find new inhibitors of dormant M. tuberculosis.


Sign in / Sign up

Export Citation Format

Share Document